BioAtla, Inc. (BCAB)
0.8053
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 16:00
0.8053
0.00 (0.00%)
After-Hours: 20:00
BioAtla Total Liabilities (Quarterly): 47.14M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Context Therapeutics, Inc. | 6.057M |
| CEL-SCI Corp. | 13.31M |
| AIM ImmunoTech, Inc. | 11.57M |
| IGC Pharma, Inc. | 1.651M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.91M |
| Shareholders Equity (Quarterly) | -31.24M |
| Debt to Equity Ratio | -0.1979 |
| Current Ratio | 0.5377 |
| Net Debt Paydown Yield | -2.23% |